13F

Stock

Taysha Gene Therapies, Inc.

TSHA · held by 3 managers

Reported value

$746.7K

Holders

3

+0 new · −0 exited

Holders’ est. mark

−$105K

Price effect on 3 books still in the name

Largest holder

$586.7K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC335.2K$586.7K−$79.1KAdded$74.8K
Leonteq Securities AG80K$138.4K−$22.4KCut−$22.4K
Marex Group plc12.5K$21.6K−$3.5KCut−$3.5K

Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.